Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation

• Published in: PloS one Vol. 12; no. 9; p. e0185496
• Main Authors: von Volkmann, Hilde L., Brønstad, Ingeborg, Gilja, Odd Helge, R. Tronstad, Rune, Sangnes, Dag Andre, Nortvedt, Ragnar, Hausken, Trygve, Dimcevski, Georg, Fiskerstrand, Torunn, Nylund, Kim
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 28.09.2017; Public Library of Science (PLoS)
• Subjects: Adult; Aged; Biology and Life Sciences; Body Fluids; Capsule Endoscopy; Care and treatment; Causes of; Clinical medicine; Colon; Constipation; Control charts; Diarrhea; Diarrhea - blood; Diarrhea - diagnostic imaging; Diarrhea - genetics; Diarrhea - physiopathology; Digestive system; Digestive tract; Duodenum; Female; Gastric motility; Gastroenterology; Gastrointestinal tract; Gastrointestinal Transit - physiology; Gene mutation; Genetic aspects; Guanylate cyclase; Health aspects; Hormones; Hormones - blood; Hospitals; Humans; Hydration; Hydrogen-Ion Concentration; Intestines - pathology; Intestines - physiopathology; Irritable bowel syndrome; Male; Medicine; Medicine and Health Sciences; Middle Aged; Motility; Muscle Contraction; Mutation; Mutation - genetics; Observer Variation; Pain; Patients; pH effects; Pharmacology; Physiological aspects; Plasma levels; Pressure; Receptors, Enterotoxin; Receptors, Guanylate Cyclase-Coupled - genetics; Receptors, Peptide - genetics; Serotonin; Small intestine; Time Factors; Transit time; Ultrasonic imaging; Ultrasound; Young Adult; Norway
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0185496

Increased intestinal hydration by activation of the epithelial enzyme linked receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation. Activating mutations in the GUCY2C gene encoding GC-C cause Familial GUCY2C diarrhea syndrome (FGDS) which has been diagnosed with severe dysmotility. To investigate gut motility and hormones before and after a meal in FGDS patients and compare with healthy controls (HC). Bristol stool chart and stool frequency was assessed. Before and after a meal occlusive and non-occlusive contractions were obtained using ultrasound. A wireless motility capsule (WMC) recorded gut transit time, pH, contractions and pressure. Plasma levels of selected gut hormones were measured at different time points. The FGDS patients had 4 (range 1-10) loose stools/day and prolonged total gut transit time compared to HC, 55.5 h vs 28.5 h, respectively,with significantly increased colon transit time. In FGDS patients, pH in duodenum, small bowel and colon was increased and the number of contractions and the intraluminal pressure were significantly decreased, measured by WMC. Ultrasound showed in small bowel increased number of non-occlusive contractions in the FGDS patients. Serotonin (5-HT) plasma levels in the HC peaked 30 min after the meal, while the FGDS patients had no response. Despite having diarrhea, the FGDS patients have prolonged transit time through the gut compared to HC, particularly in colon. The reduced number of intestinal contractions and lack of 5-HT release after a meal in FGDS patients surprisingly resemble colonic motility disturbances seen in patients with constipation.